Article thumbnail

The Inflammasomes: Molecular Effectors of Host Resistance Against Bacterial, Viral, Parasitic, and Fungal Infections

By Alexander Skeldon and Maya Saleh

Abstract

The inflammasomes are large multi-protein complexes scaffolded by cytosolic pattern recognition receptors (PRRs) that form an important part of the innate immune system. They are activated following the recognition of microbial-associated molecular patterns or host-derived danger signals (danger-associated molecular patterns) by PRRs. This recognition results in the recruitment and activation of the pro-inflammatory protease caspase-1, which cleaves its preferred substrates pro-interleukin-1β (IL-1β) and pro-IL-18 into their mature biologically active cytokine forms. Through processing of a number of other cellular substrates, caspase-1 is also required for the release of “alarmins” and the induction and execution of an inflammatory form of cell death termed pyroptosis. A growing spectrum of inflammasomes have been identified in the host defense against a variety of pathogens. Reciprocally, pathogens have evolved effector strategies to antagonize the inflammasome pathway. In this review we discuss recent developments in the understanding of inflammasome-mediated recognition of bacterial, viral, parasitic, and fungal infections and the beneficial or detrimental effects of inflammasome signaling in host resistance

Topics: Microbiology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3109312
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1992). A kinetic study of immune mediators in the lungs of mice infected with influenza A virus.
  2. (2008). A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.
  3. (1992). A novel heterodimeric cysteine protease is required for interleukin-1-beta processing in monocytes.
  4. (2005). A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection.
  5. (2010). Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis.
  6. (1997). Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme.
  7. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration.
  8. (2008). Active caspase-1 is a regulator of unconventional protein secretion.
  9. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA.
  10. (2003). An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid.
  11. (2009). An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans.
  12. (2008). Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1- dependent pyroptosis via distinct mechanisms.
  13. (2008). Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome.
  14. (2003). Anthrax toxin.
  15. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.
  16. (2010). Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.
  17. (2007). Birc1e/Naip5 rapidly antagonizes modulation of phagosome maturation by Legionella pneumophila.
  18. (2010). Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo.
  19. (1997). Caspase-1 processes IFN-gammainducing factor and regulates LPSinduced IFN-gamma production.
  20. (2010). Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.
  21. (2006). Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection.
  22. (2010). Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signaling.
  23. (2009). Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection.
  24. (2008). Cell death in the host response to infection.
  25. (2007). Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation.
  26. (2010). Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.
  27. (2007). COPs and POPs: modulators of inflammasome activity.
  28. (2008). Critical function for Naip5 in inflammasome activation by a conserved carboxyterminal domain of flagellin.
  29. (2006). Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA.
  30. (2006). Cryopyrin activates the inflammasome in response to toxins and ATP.
  31. (2009). Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome.
  32. (2010). Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2.
  33. (2010). Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence.
  34. Cutting edge: priming of NK cells by IL-18.
  35. (2010). Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/ Nlrp1b.
  36. (2006). Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf.
  37. (2006). Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in Salmonella-infected macrophages.
  38. (2006). Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection.
  39. (2008). Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm.
  40. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.
  41. (2007). Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages.
  42. (2007). Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 acti-www.frontiersin.org
  43. (2006). Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18 secretion in response to Listeria monocytogenes.
  44. (2006). Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
  45. (2006). Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice.
  46. (2008). ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection.
  47. (2010). Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome.
  48. (2000). Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma.
  49. (2006). Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity.
  50. (2006). Francisella tularensis travels a novel, twisted road within macrophages.
  51. (2010). Genetics of inflammasomeassociated disorders: a lesson in the guiding principals of inflammasome function.
  52. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome.
  53. (2010). Granuloma formation and host defense
  54. (2007). Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator.
  55. (2003). Host recognition of bacterial muramyl dipeptide mediated through NOD2.
  56. (2010). IL-1 pathways in inflammation and human diseases.
  57. (2007). IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
  58. (1999). IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.
  59. (1999). IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
  60. (2007). Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.
  61. (2001). Immunology of tuberculosis.
  62. (2010). In macrophages, caspase-1 activation by SopE and the type III secretion system-1 of S. typhimurium can proceed in the absence of flagellin.
  63. (2009). Inflammasome recognition of influenza virus is essential for adaptive immune responses.
  64. (2005). Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18.
  65. (2010). Influenza virus activates inflammasomes via its intracellular M2 ion channel.
  66. (2007). Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium.
  67. (2010). Innate immune mechanisms for recognition and uptake of Candida species.
  68. (2011). Innate immune mechanisms of colitis and colitis-associated colorectal cancer.
  69. Innate immunity against Francisella tularensis is dependent on the ASC/ caspase-1 axis.
  70. (2005). Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.
  71. (2000). Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.
  72. (2006). Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.
  73. (2008). Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages.
  74. (2010). Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes.
  75. (2010). Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes.
  76. (2009). Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan.
  77. (2010). Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome.
  78. (2010). Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol.
  79. (2010). Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.
  80. (2009). Malarial hemozoin is a Nalp3 inflammasome activating danger signal.
  81. (2008). Maturation modulates caspase-1-independent responses of dendritic cells to anthrax lethal toxin.
  82. (2009). Mechanism of Bcl-2 and Bcl-X-L inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization.
  83. (2009). Molecular mechanisms of Salmonella virulence and host resistance.
  84. (2008). Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection.
  85. (1998). Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE.
  86. (2008). Mycobacterium tuberculosis prevents inflammasome activation.
  87. (2010). Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome.
  88. (2008). NAIP and Ipaf control Legionella pneumophila replication in human cells.
  89. (2003). Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila.
  90. (2010). NALP3 is not necessary for early protection against experimental tuberculosis.
  91. (2008). NOD-like receptors (NLRs): bona fide intracellular microbial sensors.
  92. (2003). Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan.
  93. (1997). Nonfilamentous C. albicans mutants are avirulent.
  94. (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release inflammatory caspases and processing of proIL-beta.
  95. (2010). paper pending published: 04
  96. Pore formation triggered by Legionella spp. is an Nlrc4 inflammasomedependent host cell response that precedes pyroptosis.
  97. (2007). Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing.
  98. (1998). Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
  99. (2008). Pseudomonas aeruginosa activates caspase 1 through Ipaf.
  100. (2009). Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid.
  101. (2010). Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production.
  102. (2007). Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.
  103. (2006). Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf.
  104. (2007). Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways.
  105. (2009). Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators
  106. (2009). RIG-I-like receptors: sensing and responding to RNA virus infection.
  107. (2006). Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis.
  108. (2004). Roles of caspase-1 in Listeria infection in mice.
  109. (1998). S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells.
  110. (2008). Salmonellae interplay with host cells.
  111. (2009). Staphylococcus aureus α-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.
  112. (2010). Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS
  113. (2009). Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence.
  114. (2005). Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.
  115. (2008). Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes.
  116. (2004). Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta.
  117. (2010). The AIM2 inflammasome is critical for innate immunity to Francisella tularensis.
  118. (2010). The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.
  119. (2006). The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection.
  120. (2007). The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock.
  121. (2002). The economic and social burden of malaria.
  122. (2008). The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response.
  123. (2002). The inflammasome: a molecular platform triggering activation of
  124. (2011). The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections.
  125. (2010). The inflammasomes.
  126. (2009). The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1.
  127. (2009). The Legionella pneumophila replication vacuole: making a cosy niche inside host cells.
  128. (2009). The MogR transcriptional repressor regulates nonhierarchal expression of flagellar motility genes and virulence in Listeria monocytogenes.
  129. (2008). The Nalp3 inflammasome is essential for the development of silicosis.
  130. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.
  131. (2010). The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.
  132. (2009). The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.
  133. (2010). The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.
  134. (2008). The Nod-like receptor (NLR) family: a tale of similarities and differences.
  135. (2007). The Nodlike receptor family member Naip5/ Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation.
  136. (2009). The RD1 locus in the Mycobacterium tuberculosis genome contributes to activation of caspase-1 via induction of potassium ion efflux in infected macrophages.
  137. (2010). The role of potassium in inflammasome activation by bacteria.
  138. (2009). The S. typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation.
  139. (1999). The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1.
  140. (2011). This is an open-access article subject to an exclusive license agreement between the authors and Frontiers Media SA, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
  141. (2007). Type I interferon signaling is required for activation of the inflammasome during Francisella infection.
  142. (1999). Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.